Cargando…

Hepatic NF‐κB‐Inducing Kinase and Inhibitor of NF‐κB Kinase Subunit α Promote Liver Oxidative Stress, Ferroptosis, and Liver Injury

Drug‐induced hepatotoxicity limits development of new effective medications. Drugs and numerous endogenous/exogenous agents are metabolized/detoxified by hepatocytes, during which reactive oxygen species (ROS) are generated as a by‐product. ROS has broad adverse effects on liver function and integri...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Xiao, Zhang, Zhiguo, Shen, Hong, Xiong, Yi, Shah, Yatrik M., Liu, Yong, Fan, Xue‐Gong, Rui, Liangyou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485893/
https://www.ncbi.nlm.nih.gov/pubmed/34558831
http://dx.doi.org/10.1002/hep4.1757
_version_ 1784577626704183296
author Zhong, Xiao
Zhang, Zhiguo
Shen, Hong
Xiong, Yi
Shah, Yatrik M.
Liu, Yong
Fan, Xue‐Gong
Rui, Liangyou
author_facet Zhong, Xiao
Zhang, Zhiguo
Shen, Hong
Xiong, Yi
Shah, Yatrik M.
Liu, Yong
Fan, Xue‐Gong
Rui, Liangyou
author_sort Zhong, Xiao
collection PubMed
description Drug‐induced hepatotoxicity limits development of new effective medications. Drugs and numerous endogenous/exogenous agents are metabolized/detoxified by hepatocytes, during which reactive oxygen species (ROS) are generated as a by‐product. ROS has broad adverse effects on liver function and integrity, including damaging hepatocyte proteins, lipids, and DNA and promoting liver inflammation and fibrosis. ROS in concert with iron overload drives ferroptosis. Hepatic nuclear factor kappa B (NF‐κB)‐inducing kinase (NIK) is aberrantly activated in a broad spectrum of liver disease. NIK phosphorylates and activates inhibitor of NF‐κB kinase subunit alpha (IKKα), and the hepatic NIK/IKKα cascade suppresses liver regeneration. However, the NIK/IKKα pathway has not been explored in drug‐induced liver injury. Here, we identify hepatic NIK as a previously unrecognized mediator for acetaminophen (APAP)‐induced acute liver failure. APAP treatment increased both NIK transcription and NIK protein stability in primary hepatocytes as well as in liver in mice. Hepatocyte‐specific overexpression of NIK augmented APAP‐induced liver oxidative stress in mice and increased hepatocyte death and mortality in a ROS‐dependent manner. Conversely, hepatocyte‐specific ablation of NIK or IKKα mitigated APAP‐elicited hepatotoxicity and mortality. NIK increased lipid peroxidation and cell death in APAP‐stimulated primary hepatocytes. Pretreatment with antioxidants or ferroptosis inhibitors blocked NIK/APAP‐induced hepatocyte death. Conclusion: We unravel a previously unrecognized NIK/IKKα/ROS/ferroptosis axis engaged in liver disease progression.
format Online
Article
Text
id pubmed-8485893
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-84858932021-10-07 Hepatic NF‐κB‐Inducing Kinase and Inhibitor of NF‐κB Kinase Subunit α Promote Liver Oxidative Stress, Ferroptosis, and Liver Injury Zhong, Xiao Zhang, Zhiguo Shen, Hong Xiong, Yi Shah, Yatrik M. Liu, Yong Fan, Xue‐Gong Rui, Liangyou Hepatol Commun Original Articles Drug‐induced hepatotoxicity limits development of new effective medications. Drugs and numerous endogenous/exogenous agents are metabolized/detoxified by hepatocytes, during which reactive oxygen species (ROS) are generated as a by‐product. ROS has broad adverse effects on liver function and integrity, including damaging hepatocyte proteins, lipids, and DNA and promoting liver inflammation and fibrosis. ROS in concert with iron overload drives ferroptosis. Hepatic nuclear factor kappa B (NF‐κB)‐inducing kinase (NIK) is aberrantly activated in a broad spectrum of liver disease. NIK phosphorylates and activates inhibitor of NF‐κB kinase subunit alpha (IKKα), and the hepatic NIK/IKKα cascade suppresses liver regeneration. However, the NIK/IKKα pathway has not been explored in drug‐induced liver injury. Here, we identify hepatic NIK as a previously unrecognized mediator for acetaminophen (APAP)‐induced acute liver failure. APAP treatment increased both NIK transcription and NIK protein stability in primary hepatocytes as well as in liver in mice. Hepatocyte‐specific overexpression of NIK augmented APAP‐induced liver oxidative stress in mice and increased hepatocyte death and mortality in a ROS‐dependent manner. Conversely, hepatocyte‐specific ablation of NIK or IKKα mitigated APAP‐elicited hepatotoxicity and mortality. NIK increased lipid peroxidation and cell death in APAP‐stimulated primary hepatocytes. Pretreatment with antioxidants or ferroptosis inhibitors blocked NIK/APAP‐induced hepatocyte death. Conclusion: We unravel a previously unrecognized NIK/IKKα/ROS/ferroptosis axis engaged in liver disease progression. John Wiley and Sons Inc. 2021-07-01 /pmc/articles/PMC8485893/ /pubmed/34558831 http://dx.doi.org/10.1002/hep4.1757 Text en © 2021 The Authors. Hepatology Communications published by Wiley Periodicals LLC on behalf of the American Association for the Study of Liver Diseases. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Zhong, Xiao
Zhang, Zhiguo
Shen, Hong
Xiong, Yi
Shah, Yatrik M.
Liu, Yong
Fan, Xue‐Gong
Rui, Liangyou
Hepatic NF‐κB‐Inducing Kinase and Inhibitor of NF‐κB Kinase Subunit α Promote Liver Oxidative Stress, Ferroptosis, and Liver Injury
title Hepatic NF‐κB‐Inducing Kinase and Inhibitor of NF‐κB Kinase Subunit α Promote Liver Oxidative Stress, Ferroptosis, and Liver Injury
title_full Hepatic NF‐κB‐Inducing Kinase and Inhibitor of NF‐κB Kinase Subunit α Promote Liver Oxidative Stress, Ferroptosis, and Liver Injury
title_fullStr Hepatic NF‐κB‐Inducing Kinase and Inhibitor of NF‐κB Kinase Subunit α Promote Liver Oxidative Stress, Ferroptosis, and Liver Injury
title_full_unstemmed Hepatic NF‐κB‐Inducing Kinase and Inhibitor of NF‐κB Kinase Subunit α Promote Liver Oxidative Stress, Ferroptosis, and Liver Injury
title_short Hepatic NF‐κB‐Inducing Kinase and Inhibitor of NF‐κB Kinase Subunit α Promote Liver Oxidative Stress, Ferroptosis, and Liver Injury
title_sort hepatic nf‐κb‐inducing kinase and inhibitor of nf‐κb kinase subunit α promote liver oxidative stress, ferroptosis, and liver injury
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485893/
https://www.ncbi.nlm.nih.gov/pubmed/34558831
http://dx.doi.org/10.1002/hep4.1757
work_keys_str_mv AT zhongxiao hepaticnfkbinducingkinaseandinhibitorofnfkbkinasesubunitapromoteliveroxidativestressferroptosisandliverinjury
AT zhangzhiguo hepaticnfkbinducingkinaseandinhibitorofnfkbkinasesubunitapromoteliveroxidativestressferroptosisandliverinjury
AT shenhong hepaticnfkbinducingkinaseandinhibitorofnfkbkinasesubunitapromoteliveroxidativestressferroptosisandliverinjury
AT xiongyi hepaticnfkbinducingkinaseandinhibitorofnfkbkinasesubunitapromoteliveroxidativestressferroptosisandliverinjury
AT shahyatrikm hepaticnfkbinducingkinaseandinhibitorofnfkbkinasesubunitapromoteliveroxidativestressferroptosisandliverinjury
AT liuyong hepaticnfkbinducingkinaseandinhibitorofnfkbkinasesubunitapromoteliveroxidativestressferroptosisandliverinjury
AT fanxuegong hepaticnfkbinducingkinaseandinhibitorofnfkbkinasesubunitapromoteliveroxidativestressferroptosisandliverinjury
AT ruiliangyou hepaticnfkbinducingkinaseandinhibitorofnfkbkinasesubunitapromoteliveroxidativestressferroptosisandliverinjury